Literature DB >> 30053529

Allergic conversion of protective mucosal immunity against nasal bacteria in patients with chronic rhinosinusitis with nasal polyposis.

Kazuya Takeda1, Shuhei Sakakibara2, Kazuo Yamashita3, Daisuke Motooka4, Shota Nakamura4, Marwa Ali El Hussien5, Jun Katayama5, Yohei Maeda6, Masanobu Nakata7, Shigeyuki Hamada8, Daron M Standley9, Masaki Hayama6, Takashi Shikina6, Hidenori Inohara6, Hitoshi Kikutani10.   

Abstract

BACKGROUND: Chronic rhinosinusitis with nasal polyposis (CRSwNP) is characterized by eosinophilic inflammation and polyposis at the nose and paranasal sinus and a high concentration of IgE in nasal polyps (NPs). The causative antigen and pathogenesis of CRSwNP remain unknown.
OBJECTIVE: We aimed to identify reactive allergens of IgE antibodies produced locally in NPs of patients with CRSwNP. We also attempted to unravel the differentiation pathway of IgE-producing B cells in NPs.
METHODS: IgE reactivity of patients with CRSwNP was investigated by characterizing single cell-derived mAbs. T-cell response against identified allergens was investigated in vitro. NP-infiltrating lymphocytes were characterized by using flow cytometry. Immunoglobulins expressed in NPs were analyzed by using high-throughput DNA sequencing for immunoglobulin.
RESULTS: About 20% of isolated IgE antibodies derived from NP-residing plasmablasts specifically recognized surface determinants of nasal bacteria, such as Staphylococcus aureus, Streptococcus pyogenes, and Haemophilus influenzae. A TH2 response against S pyogenes was observed in patients with CRSwNP. Flow cytometric analysis revealed sizable germinal center B-like cell and plasmablast subsets expressing IgE on the cell surface in NPs. High-throughput DNA sequencing immunoglobulin analysis highlighted the clonal connectivity of IgE with IgG and IgA1. The Iε-Cα1 circle transcript was detected in NPs.
CONCLUSIONS: In patients with CRSwNP, nasal bacteria-reactive B cells differentiate into IgE-producing B cells through IgG/IgA1-IgE class switching, suggesting that allergic conversion of the mucosal response against nasal bacteria underlies disease pathogenesis.
Copyright © 2018 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic rhinosinusitis with nasal polyposis; IgE; T(H)2 inflammation; high-throughput immunoglobulin analysis; human mAb

Year:  2018        PMID: 30053529     DOI: 10.1016/j.jaci.2018.07.006

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  14 in total

Review 1.  Use of endotypes, phenotypes, and inflammatory markers to guide treatment decisions in chronic rhinosinusitis.

Authors:  Anna G Staudacher; Anju T Peters; Atsushi Kato; Whitney W Stevens
Journal:  Ann Allergy Asthma Immunol       Date:  2020-01-30       Impact factor: 6.347

Review 2.  The Role of Staphylococcus aureus in Patients with Chronic Sinusitis and Nasal Polyposis.

Authors:  Thad W Vickery; Vijay R Ramakrishnan; Jeffrey D Suh
Journal:  Curr Allergy Asthma Rep       Date:  2019-03-11       Impact factor: 4.806

Review 3.  Pathophysiologic mechanisms of chronic rhinosinusitis and their roles in emerging disease endotypes.

Authors:  Ping-Ping Cao; Zhi-Chao Wang; Robert P Schleimer; Zheng Liu
Journal:  Ann Allergy Asthma Immunol       Date:  2018-10-13       Impact factor: 6.347

4.  IL-5Rα marks nasal polyp IgG4- and IgE-expressing cells in aspirin-exacerbated respiratory disease.

Authors:  Kathleen M Buchheit; Daniel F Dwyer; Jose Ordovas-Montanes; Howard R Katz; Erin Lewis; Marko Vukovic; Juying Lai; Lora G Bankova; Neil Bhattacharyya; Alex K Shalek; Nora A Barrett; Joshua A Boyce; Tanya M Laidlaw
Journal:  J Allergy Clin Immunol       Date:  2020-03-19       Impact factor: 10.793

Review 5.  Biologics for the Treatment of Allergic Rhinitis, Chronic Rhinosinusitis, and Nasal Polyposis.

Authors:  William Eschenbacher; Matthew Straesser; Alice Knoeddler; Rung-Chi Li; Larry Borish
Journal:  Immunol Allergy Clin North Am       Date:  2020-09-09       Impact factor: 3.479

6.  Differences in the distribution of CD20, CD3, CD34 and CD45RO in nasal mucosa and polyps from patients with chronic rhinosinusitis.

Authors:  Mihaela Mitroi; Dana Albulescu; Alina Capitanescu; Anca Oana Docea; Gabriela Musat; George Mitroi; Ovidiu Zlatian; Aristidis Tsatsakis; George Tzanakakis; Demetrios A Spandidos; Daniela Calina
Journal:  Mol Med Rep       Date:  2019-02-05       Impact factor: 2.952

Review 7.  Sinus Infections, Inflammation, and Asthma.

Authors:  Anna G Staudacher; Whitney W Stevens
Journal:  Immunol Allergy Clin North Am       Date:  2019-05-16       Impact factor: 3.479

Review 8.  Monoclonal Antibodies and Airway Diseases.

Authors:  Annina Lyly; Anu Laulajainen-Hongisto; Philippe Gevaert; Paula Kauppi; Sanna Toppila-Salmi
Journal:  Int J Mol Sci       Date:  2020-12-13       Impact factor: 5.923

Review 9.  The central role of the nasal microenvironment in the transmission, modulation, and clinical progression of SARS-CoV-2 infection.

Authors:  Oreste Gallo; Luca Giovanni Locatello; Alessio Mazzoni; Luca Novelli; Francesco Annunziato
Journal:  Mucosal Immunol       Date:  2020-11-26       Impact factor: 7.313

10.  Mitochondrial DNA enhance innate immune responses in neuromyelitis optica by monocyte recruitment and activation.

Authors:  Mikito Shimizu; Tatsusada Okuno; Makoto Kinoshita; Hisae Sumi; Harutoshi Fujimura; Kazuya Yamashita; Tomoyuki Sugimoto; Shuhei Sakakibara; Kaori Sakakibara; Toru Koda; Satoru Tada; Teruyuki Ishikura; Hisashi Murata; Shohei Beppu; Naoyuki Shiraishi; Yasuko Sugiyama; Yuji Nakatsuji; Atsushi Kumanogoh; Hideki Mochizuki
Journal:  Sci Rep       Date:  2020-08-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.